NewsBenzingaパイパー・サンドラー、アクソーム・セラピューティクスに対する過大評価を再確認し、株価目標を258ドルに維持 パイパー・サンドラー、アクソーム・セラピューティクスに対する過大評価を再確認し、株価目標を258ドルに維持 Benzinga 2026.09.18 16:39 (GMT+0) Open on Benzinga Other news Data: ZRO, XPL and other tokens to see major unlocks next week, with ZRO unlocking about $43.3 million Trader moves 1.662 million ONDO and nearly 30,000 LINK to Binance, with unrealized gains of over $400,000 after 5 months StoneCo: Wait For Signs Of Credit Stabilization (NASDAQ:STNE) This Market Is Rotten Under The Hood - I'm Making These 3 Moves Why 5% Treasuries Don't Kill The REIT Case Elon Musk Says Optimus, Cybercab Will Be ‘the Vast Majority’ of Tesla’s Value
Data: ZRO, XPL and other tokens to see major unlocks next week, with ZRO unlocking about $43.3 million
Trader moves 1.662 million ONDO and nearly 30,000 LINK to Binance, with unrealized gains of over $400,000 after 5 months
